SOLIGENIX, INC. — Director's Dealing 2022

Jan 4, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2022-01-03

Reporting Person: SCHABER CHRISTOPHER J (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-03	Option (Right to Buy)	$0.69	A	60000	Acquired	2032-01-02	Common Stock (60000)	Direct

Footnotes

F1: The stock option vested immediately as to 15,000 shares and vests as to the remainder at a rate of 3,750 of the shares on each three (3) month anniversary of January 3, 2022.